CNTA
Centessa Pharmaceuticals
CNTA
CNTA
114 hedge funds and large institutions have $2.08B invested in Centessa Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 36 increasing their positions, 36 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9.91% more ownership
Funds ownership: 84.45% → 94.36% (+9.9%)
0% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 36
97% less call options, than puts
Call options by funds: $117K | Put options by funds: $3.69M
Holders
114
Holding in Top 10
12
Calls
$117K
Puts
$3.69M
Top Buyers
| 1 | +$60.5M | |
| 2 | +$17.8M | |
| 3 | +$15.5M | |
| 4 |
CC
Commodore Capital
New York
|
+$14.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.3M |
Top Sellers
| 1 | -$51.5M | |
| 2 | -$16.2M | |
| 3 | -$10.2M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$9.44M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.48M |